Factors such as altered drug absorption and decreased clearance due to impaired renal or hepatic activity can significantly affect how drugs will behave with use.
As many as 300,000 Canadians could have CD; however, many remain undiagnosed. The disease can be difficult to diagnose since it can present with a variety of symptoms at any point in life.